Callan Capital’s Infinity Pharmaceuticals, Inc. INFI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | – | Sell |
-158,500
| Closed | -$33.4K | – | 212 |
|
|
2023
Q2 | $33.4K | Hold |
158,500
| – | – | ﹤0.01% | 180 |
|
|
2023
Q1 | $25.4K | Hold |
158,500
| – | – | ﹤0.01% | 180 |
|
|
2022
Q4 | $88K | Buy |
+158,500
| New | +$88K | 0.01% | 181 |
|
|
2022
Q1 | – | Sell |
-146,200
| Closed | -$329K | – | 140 |
|
|
2021
Q4 | $329K | Hold |
146,200
| – | – | 0.05% | 96 |
|
|
2021
Q3 | $500K | Buy |
146,200
+24,400
| +20% | +$83.4K | 0.08% | 66 |
|
|
2021
Q2 | $364K | Buy |
+121,800
| New | +$364K | 0.06% | 72 |
|
|
2021
Q1 | – | Sell |
-73,200
| Closed | -$155K | – | 88 |
|
|
2020
Q4 | $155K | Buy |
+73,200
| New | +$155K | 0.03% | 80 |
|